-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of the State Food and Drug Administration showed that Shandong New Times Pharmaceutical's Fasudil Hydrochloride Injection passed the consistency evaluation
.
According to data from Minet.
com, in 2020, the sales volume of fasudil injection, a terminal of public medical institutions in China, will be close to 400 million yuan
.
At present, Shandong New Times (excluding subsidiaries) has passed or deemed to pass the consistency evaluation of 17 varieties, of which 8 are injections
.
.
According to data from Minet.
com, in 2020, the sales volume of fasudil injection, a terminal of public medical institutions in China, will be close to 400 million yuan
.
At present, Shandong New Times (excluding subsidiaries) has passed or deemed to pass the consistency evaluation of 17 varieties, of which 8 are injections
.
Source: State Food and Drug Administration official website
Fasudil is an anti-vasospasm drug, which can dilate blood vessels by inhibiting the phosphorylation of myosin light chain in the final stage of smooth muscle contraction.
Spasticity and consequent symptoms of cerebral ischemia
.
Spasticity and consequent symptoms of cerebral ischemia
.
According to data from Minet.
com, in 2016, Fasudil injection reached a sales peak of nearly 800 million in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions), and has since declined.
, the sales volume in 2020 will be close to 400 million yuan
.
com, in 2016, Fasudil injection reached a sales peak of nearly 800 million in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions), and has since declined.
, the sales volume in 2020 will be close to 400 million yuan
.
Review of Fasudil Injection
Source: Minet Consistency Evaluation Database
Including Shandong New Times, there are currently 8 companies whose fasudil hydrochloride injection has passed the consistency evaluation, and the product has been included in the fifth batch of centralized procurement.
4 companies, Yangzijiang Guangzhou Hairui Pharmaceutical Co.
, Ltd.
, won the bid
.
4 companies, Yangzijiang Guangzhou Hairui Pharmaceutical Co.
, Ltd.
, won the bid
.
Shandong New Times Injection Review Status
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
Fasudil hydrochloride injection is the first product approved by Shandong New Times in 2022.
So far, 17 products have passed or are deemed to have passed the consistency evaluation, of which 8 are injections
.
So far, 17 products have passed or are deemed to have passed the consistency evaluation, of which 8 are injections
.
A few days ago, the official website of the State Food and Drug Administration showed that Shandong New Times Pharmaceutical's Fasudil Hydrochloride Injection passed the consistency evaluation
.
According to data from Minet.
com, in 2020, the sales volume of fasudil injection, a terminal of public medical institutions in China, will be close to 400 million yuan
.
At present, Shandong New Times (excluding subsidiaries) has passed or deemed to pass the consistency evaluation of 17 varieties, of which 8 are injections
.
.
According to data from Minet.
com, in 2020, the sales volume of fasudil injection, a terminal of public medical institutions in China, will be close to 400 million yuan
.
At present, Shandong New Times (excluding subsidiaries) has passed or deemed to pass the consistency evaluation of 17 varieties, of which 8 are injections
.
Source: State Food and Drug Administration official website
Fasudil is an anti-vasospasm drug, which can dilate blood vessels by inhibiting the phosphorylation of myosin light chain in the final stage of smooth muscle contraction.
Spasticity and consequent symptoms of cerebral ischemia
.
Spasticity and consequent symptoms of cerebral ischemia
.
According to data from Minet.
com, in 2016, Fasudil injection reached a sales peak of nearly 800 million in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions), and has since declined.
, the sales volume in 2020 will be close to 400 million yuan
.
com, in 2016, Fasudil injection reached a sales peak of nearly 800 million in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions), and has since declined.
, the sales volume in 2020 will be close to 400 million yuan
.
Review of Fasudil Injection
Source: Minet Consistency Evaluation Database
Including Shandong New Times, there are currently 8 companies whose fasudil hydrochloride injection has passed the consistency evaluation, and the product has been included in the fifth batch of centralized procurement.
4 companies, Yangzijiang Guangzhou Hairui Pharmaceutical Co.
, Ltd.
, won the bid
.
4 companies, Yangzijiang Guangzhou Hairui Pharmaceutical Co.
, Ltd.
, won the bid
.
Shandong New Times Injection Review Status
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
Fasudil hydrochloride injection is the first product approved by Shandong New Times in 2022.
So far, 17 products have passed or are deemed to have passed the consistency evaluation, of which 8 are injections
.
So far, 17 products have passed or are deemed to have passed the consistency evaluation, of which 8 are injections
.
A few days ago, the official website of the State Food and Drug Administration showed that Shandong New Times Pharmaceutical's Fasudil Hydrochloride Injection passed the consistency evaluation
.
According to data from Minet.
com, in 2020, the sales volume of fasudil injection, a terminal of public medical institutions in China, will be close to 400 million yuan
.
At present, Shandong New Times (excluding subsidiaries) has passed or deemed to pass the consistency evaluation of 17 varieties, of which 8 are injections
.
.
According to data from Minet.
com, in 2020, the sales volume of fasudil injection, a terminal of public medical institutions in China, will be close to 400 million yuan
.
At present, Shandong New Times (excluding subsidiaries) has passed or deemed to pass the consistency evaluation of 17 varieties, of which 8 are injections
.
Source: State Food and Drug Administration official website
Fasudil is an anti-vasospasm drug, which can dilate blood vessels by inhibiting the phosphorylation of myosin light chain in the final stage of smooth muscle contraction.
Spasticity and consequent symptoms of cerebral ischemia
.
Spasticity and consequent symptoms of cerebral ischemia
.
According to data from Minet.
com, in 2016, Fasudil injection reached a sales peak of nearly 800 million in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions), and has since declined.
, the sales volume in 2020 will be close to 400 million yuan
.
hospital hospital hospitalcom, in 2016, Fasudil injection reached a sales peak of nearly 800 million in China's urban public hospitals , county-level public hospitals, urban community centers and township health centers (referred to as Chinese public medical institutions), and has since declined.
, the sales volume in 2020 will be close to 400 million yuan
.
Review of Fasudil Injection
Source: Minet Consistency Evaluation Database
Including Shandong New Times, there are currently 8 companies whose fasudil hydrochloride injection has passed the consistency evaluation, and the product has been included in the fifth batch of centralized procurement.
4 companies, Yangzijiang Guangzhou Hairui Pharmaceutical Co.
, Ltd.
, won the bid
.
enterprise enterprise enterprise4 companies, Yangzijiang Guangzhou Hairui Pharmaceutical Co.
, Ltd.
, won the bid
.
Shandong New Times Injection Review Status
Source: MED2.
0 China Drug Evaluation Database
0 China Drug Evaluation Database
Fasudil hydrochloride injection is the first product approved by Shandong New Times in 2022.
So far, 17 products have passed or are deemed to have passed the consistency evaluation, of which 8 are injections
.
So far, 17 products have passed or are deemed to have passed the consistency evaluation, of which 8 are injections
.
